Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP502534.RAyvUvfn-O-zzSrOk5cW5aG3tcMGViLc-y-sp_GE_YSd4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502534.RAyvUvfn-O-zzSrOk5cW5aG3tcMGViLc-y-sp_GE_YSd4130_assertion type Assertion NP502534.RAyvUvfn-O-zzSrOk5cW5aG3tcMGViLc-y-sp_GE_YSd4130_head.
- NP502534.RAyvUvfn-O-zzSrOk5cW5aG3tcMGViLc-y-sp_GE_YSd4130_assertion description "[For TIMP2, a moderately reduced risk of the cancer (OR, 0.76; 95% CI, 0.58-0.99) was also associated with the variant allele (-418GC or CC), compared with the GG common allele.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502534.RAyvUvfn-O-zzSrOk5cW5aG3tcMGViLc-y-sp_GE_YSd4130_provenance.
- NP502534.RAyvUvfn-O-zzSrOk5cW5aG3tcMGViLc-y-sp_GE_YSd4130_assertion evidence source_evidence_literature NP502534.RAyvUvfn-O-zzSrOk5cW5aG3tcMGViLc-y-sp_GE_YSd4130_provenance.
- NP502534.RAyvUvfn-O-zzSrOk5cW5aG3tcMGViLc-y-sp_GE_YSd4130_assertion SIO_000772 14604886 NP502534.RAyvUvfn-O-zzSrOk5cW5aG3tcMGViLc-y-sp_GE_YSd4130_provenance.
- NP502534.RAyvUvfn-O-zzSrOk5cW5aG3tcMGViLc-y-sp_GE_YSd4130_assertion wasDerivedFrom befree-20140225 NP502534.RAyvUvfn-O-zzSrOk5cW5aG3tcMGViLc-y-sp_GE_YSd4130_provenance.
- NP502534.RAyvUvfn-O-zzSrOk5cW5aG3tcMGViLc-y-sp_GE_YSd4130_assertion wasGeneratedBy ECO_0000203 NP502534.RAyvUvfn-O-zzSrOk5cW5aG3tcMGViLc-y-sp_GE_YSd4130_provenance.